OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effectiveness and safety of PD-1/PD-L1 inhibitors in advanced or recurrent endometrial cancer: a systematic review and meta-analysis
Songfei Han, Cuishan Guo, Zixuan Song, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 4
Songfei Han, Cuishan Guo, Zixuan Song, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 4
Showing 4 citing articles:
Efficacy comparison of PD-1/PD-L1 inhibitor monotherapy and combination with PARPis or antiangiogenic agents in advanced or recurrent endometrial cancer: a systematic review and network meta-analysis
Shiya Ji, Xupeng Chen, Y L Yu, et al.
BMC Women s Health (2025) Vol. 25, Iss. 1
Open Access
Shiya Ji, Xupeng Chen, Y L Yu, et al.
BMC Women s Health (2025) Vol. 25, Iss. 1
Open Access
The PD-1/PD-L1 Gateway: Peripheral Immune Regulation in the Pathogenesis of Endometriosis
Małgorzata Sobstyl, Paulina Mertowska, Sebastian Mertowski, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6775-6775
Open Access | Times Cited: 1
Małgorzata Sobstyl, Paulina Mertowska, Sebastian Mertowski, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6775-6775
Open Access | Times Cited: 1
Efficacy and safety of lenvatinib plus pembrolizumab in patients with advanced and recurrent endometrial cancer: a systematic review and meta-analysis
Guangwei Yan, Yanmin Du, Huanhuan Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Guangwei Yan, Yanmin Du, Huanhuan Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Efficacy and safety of immune checkpoint inhibitors for advanced or recurrent endometrial cancer: a systematic review and network meta-analysis
Danxue Huang, Li Su, Bai Yang, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Danxue Huang, Li Su, Bai Yang, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
